Andrew Kleiboeker

Colleagues at RiverVest Venture Partners

AS

Alessandro Sette

Scientific Advisor; Professor and Member, La Jolla Institute for Immunology at RiverVest Venture Partners

AC

Andy Craig

Co-founder at RiverVest Venture Partners

CS

Corrin Short

Executive Assistant at RiverVest Venture Partners

CH

Courtney Harris

Controller at RiverVest Venture Partners

GD

Gary DeCrescenzo

Scientific Advisor; Independent Consultant, Pharmaceutical Research and Development at RiverVest Venture Partners

IZ

Isaac Zike

Managing Director at RiverVest Venture Partners

JR

Jared Rutter

Scientific Advisor; Professor of Biochemistry and HHMI Investigator, University of Utah at RiverVest Venture Partners

JW

Jay W. Schmelter

Co-founder of RiverVest Venture Partners, funding and founding life science companies

Frequently asked questions

Who is Andrew Kleiboeker?

Andrew Kleiboeker joined RiverVest as an analyst in 2020, was promoted to senior analyst in 2022 and associate in 2024. He supports due diligence on medical device investments and performs financial analysis for portfolio financings and M&A, and holds a board observer seat at InterVene Medical. He earned a B.S. in Business Administration summa cum laude from Washington University in St. Louis.

Where does Andrew Kleiboeker work?

Andrew Kleiboeker is Senior Associate at RiverVest Venture Partners.

What check size does Andrew Kleiboeker write?

Andrew Kleiboeker typically writes checks of $100K – $5M.

Where did Andrew Kleiboeker go to school?

Andrew Kleiboeker studied at Washington University in St. Louis - Olin Business School (Bachelor of Science in Business Administration (BSBA), Finance); Lee's Summit North High School.